发明名称 Therapy-infusion solution, preferably e.g. macular degeneration therapy-infusion solution, polyneuropathy therapy-infusion solution and Parkinson's therapy-infusion solution, comprises hydroxyethyl acid based solution and Ginkgo biloba
摘要 <p>Therapy-infusion solution, preferably macular degeneration therapy-infusion solution, polyneuropathy therapy-infusion solution, Parkinson's therapy-infusion solution, multiple sclerosis therapy-infusion solution or Alzheimer's therapy-infusion solution, comprises a basic solution, preferably hydroxyethyl acid based solution and Ginkgo biloba. An independent claim is also included for Ginkgo biloba, preferably an extract from a plant of Ginkgo biloba, as a drug for treating macular degeneration, polyneuropathy, Parkinson's disease, multiple sclerosis, or dementia, preferably Alzheimer's disease. ACTIVITY : Ophthalmological; Neuroprotective; Nootropic; Antiparkinsonian. No biological data given. MECHANISM OF ACTION : None given.</p>
申请公布号 DE102012002428(A1) 申请公布日期 2012.08.16
申请号 DE20121002428 申请日期 2012.02.09
申请人 PRIES, WOLFGANG 发明人 PRIES, WOLFGANG
分类号 A61K36/16;A61K31/715 主分类号 A61K36/16
代理机构 代理人
主权项
地址